ENTITY

Jeil Pharma Holdings (002620 KS)

6
Analysis
Health Care • South Korea
Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.
more
Exchange Announcement • 01 Jun 2026 20:00

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Exchange Announcement • 01 Jun 2026 16:19

Details of Corporate Governance Report (2025.12)

Exchange Announcement • 24 Mar 2026 16:02

Outcome of Annual Shareholders' Meeting

Exchange Announcement • 16 Mar 2026 15:44

Submission of Audit Report

Exchange Announcement • 05 Mar 2026 15:42

Decision on Cash Dividends and Dividends in Kind

x